KIRA TABLET
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
HYPERICUM PERFORATUM
Available from:
LICHTWER HEALTHCARE GMBH & CO KG
INN (International Name):
HYPERICUM PERFORATUM
Dosage:
180MG
Pharmaceutical form:
TABLET
Composition:
HYPERICUM PERFORATUM 180MG
Administration route:
ORAL
Units in package:
100
Prescription type:
Schedule G (CDSA IV)
Product summary:
Active ingredient group (AIG) number: 0108667024
Authorization status:
CANCELLED (UNRETURNED ANNUAL)
Authorization date:
2018-04-04
